Skip to main content
Fig. 8 | Stem Cell Research & Therapy

Fig. 8

From: Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa

Fig. 8

Best corrected visual acuity (BCVA) after the intravitreal BM-MSC injection. The changes in visual acuity (logMAR) of each month were normalized to the baseline. a The comparison of the BCVA in the study eye among groups (blue, red, and green lines indicate groups 1, 2, and 3, respectively). The comparison of the BCVA between the study eye (gray line) and fellow eye of groups 1 (b), 2 (c), and 3 (d). Data represent mean of study participants from each group; group 1: N = 7, group 2: N = 3, and group 3: N = 4 (except for M12: N = 3). Error bars indicate the SD of cells and flare value in each group. Asterisks indicate the statistical significance at P value < 0.05

Back to article page